Business Wire

Additional €86bn to Be Needed by 2030 for Sustainable Urban Mobility Transition

Share

Cities investing urgently in the shift to sustainable urban mobility in line with the Green Deal objectives could generate net benefits of up to €128 per citizen each year, finds a new report by EIT Urban Mobility, an initiative of the European Institute of Innovation and Technology (EIT), a body of the European Union. The report estimates that European cities need extra investments of 86bn in sustainable urban mobility compared to business-as-usual, leading to net benefits of up to €177bn by 2030.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211111005622/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

EIT Urban Mobility interactive tool (Graphic: EIT Urban Mobility)

Depending on the scale and type of mobility policies implemented by 2030, European cities [1] can create net benefits of up to €177bn. Of these net benefits, cities have the potential to generate €79bn in saved health costs linked to externalities avoided such as pollution and traffic accident fatalities [2]. On average, each euro invested in the transition can generate up to €3,06 by 2030 (i.e. up to €2,14 in revenues, and €0,92 in externalities savings). As world leaders stressed during COP 26 the urgency to commit to more ambitious climate policy, the report shows that investments in sustainable urban mobility options will pay off.

Following the simulation of three potential pathways to mobility sustainability, the study points out that reaching the Green Deal target [3] by 2030 would be extremely challenging and only possible through very urgent and drastic changes in the way people move in the short term (private motorized modal split needs to halve in the next 10 years). However, by 2050, when the penetration of alternative-fuelled vehicles will make up almost all the private vehicles, the implementation of more gradual and less extreme sustainable policy measures will also allow reaching the targeted CO2 emissions reduction.

Results show that by 2030 pricing schemes (Congestion and pollution charging, parking pricing, public transport integrated ticketing and tariff schemes) is the set of measures with the highest net benefits in small (50 000 – 100 000 inhabitants) and medium (100 000 – 500 000 inhabitants) cities, while Innovative Services (Demand Responsive Transport, autonomous vehicles, Intelligent Transport Systems) is the better choice for large (> 500 000 inhabitants) cities’ transition pathways.

By 2050, Innovative Services followed by Shared Mobility and Demand Management policies (Mobility as a Service, vehicle sharing, logistics delivery plans, teleworking) become the most profitable group of measures in contributing towards the Green Deal objectives in medium and large cities. Pricing Schemes remains the best option in small cities.

At EU-27 level, Shared Mobility and Demand Management policies have the highest impact on CO2 emission reduction for all city sizes, with different implications for costs and revenues based on the city size.

Transport Infrastructure measures (bus – small cities, tram – medium and large cities, metro – large cities, walking and cycling networks and facilities, urban delivery centres) are the ones with the largest differences in costs and revenues according to city sizes, from a net negative balance for large cities, to a positive net balance for small and medium cities.

Study results can be explored interactively on: https://public.tableau.com/views/CostsandBenefitsoftheUrbanMobilityTransitioninEurope/HOME?:language=en-US&:display_count=n&:origin=viz_share_link

More funding for cities on sustainable urban mobility policies would not only put them on track to meet transport CO2 reduction objectives, but also directly improve quality of life in urban areas: until 2030, their implementation in EU-27 cities has the potential to reduce mobility-related urban fatalities from 2.6 to 1.1 per 100 000 per inhabitants, lower car ownership rate from 526 to 363 cars per 1000 inhabitants and reduce the modal share of private motorised transport from 44% to 20%.

Dr Maria Tsavachidis, CEO of EIT Urban Mobility, said: “The climate emergency we face requires all of us to take immediate action, across sectors and geographies. Transport in cities is a major contributor to greenhouse gas emissions and must fundamentally transform to achieve climate neutral cities. Air and noise pollution levels, congestion, and road fatalities are daily reminders that we need now more than ever serious investments in sustainable urban mobility. Numbers clearly show these transformations are future-proof and can generate large benefits for citizens´ wellbeing and the economy, while reducing mobility-related greenhouse gas emissions.”

The study quantifies the costs and benefits of the urban mobility transition based on the implementation of three potential pathways to sustainability built on different sets of policy measures in addition to vehicle fleet decarbonization. These results are applied to different “City Prototypes” which take into account differences in cities based on their size and geographic location. Also, the study provides recommendations on the most effective groups of policies to be deployed, considering the associated costs and impact on greenhouse gas emissions reductions. The full results of the study can be explored interactively on the study’s interactive tool [4].

The report will be featured in a dedicated session of the Tomorrow.Mobility World Congress, taking place in Barcelona from 16 November to 18 November.

Transport experts TRT Trasporti e territorio [5] have carried out the analysis, using a modelling (performed with MOMOS [6]) which is based on objectives set in the Green Deal and the “Fit for 55” policy packages [7]. The scope of the analysis focuses on EU-27 cities of more than 50 000 inhabitants.

END

[1] 779 European cities of more than 50 000 inhabitants in the EU-27
[2] Benefits are calculated as revenues generated from the measures, saved costs from externalities, minus the implementation costs of the measures. So-called externalities, which relate to the costs saved coming from avoided injuries and diseases caused by air and noise pollution, as well as non-emitted greenhouse gases.
[3] -55% and -90% greenhouse gas reduction in the transport sector by 2030 and 2050, compared to 1990’s levels
[4] Interactive tool: https://public.tableau.com/views/CostsandBenefitsoftheUrbanMobilityTransitioninEurope/HOME?:language=en-US&:display_count=n&:origin=viz_share_link
[5] Trasporti e territorio: http://www.trt.it/
[6] MOMOS: http://www.trt.it/en/tools/momos/
[7] The scenarios were simulated considering a penetration of innovative vehicle technologies inspired to the EU "Fit for 55" Strategy (it is assumed a share of about 85% of electric vehicles in total European fleet by 2050). That said, the study considered only the costs affecting local authorities (such as costs for the green fuel recharging urban infrastructure to support fleet evolution). Other relevant costs associated (government incentives, costs for the automotive sector, etc.) belonging to external entities were not considered within the study.

BACKGROUND

About EIT Urban Mobility

EIT Urban Mobility, an initiative of the European Institute of Innovation and Technology (EIT), a body of the European Union, aims to accelerate solutions and the transition towards a user-centric, integrated and truly multimodal transport system. As the leading European innovation community for urban mobility, EIT Urban Mobility works to avoid fragmentation by facilitating collaboration between cities, industry, academia, research and innovation to solve the most pressing mobility challenges of cities. Using cities as living labs, its industry, research and university partners will demonstrate how new technologies can work to solve real problems in real cities by transporting people, goods and waste in smarter ways.

For more information visitwww.eiturbanmobility.eu

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press Contact Details:
Yoann Le Petit, Business Development Manager
E: yoann.lepetit@eiturbanmobility.eu
T: +49 176 63615408

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

HiddenA line styled icon from Orion Icon Library.Eye